683 Capital Management’s InflaRx IFRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.96M Hold
3,315,000
0.15% 94
2025
Q4
$3.35M Buy
3,315,000
+1,065,000
+47% +$1.32M 0.15% 98
2025
Q3
$3.02M Sell
2,250,000
-225,000
-9% -$239K 0.16% 95
2025
Q2
$1.96M Sell
2,475,000
-150,000
-6% -$177K 0.13% 103
2025
Q1
$2.68M Buy
2,625,000
+555,000
+27% +$1.05M 0.18% 102
2024
Q4
$5.11M Hold
2,070,000
0.32% 63
2024
Q3
$3.17M Hold
2,070,000
0.24% 77
2024
Q2
$3.6M Buy
2,070,000
+1,200,000
+138% +$1.76M 0.27% 70
2024
Q1
$1.34M Hold
870,000
0.1% 84
2023
Q4
$1.42M Sell
870,000
-1,480,000
-63% -$2.54M 0.12% 90
2023
Q3
$7M Buy
2,350,000
+350,000
+18% +$1.33M 0.54% 57
2023
Q2
$8.92M Buy
+2,000,000
New +$8.95M 0.64% 45

Other funds holding IFRX

683 Capital Management's IFRX Position: Q1 2026 in Review

683 Capital Management held its InflaRx (IFRX) position steady in Q1 2026 at 3,315,000 shares worth $2.96M. The position accounts for 0.15% of the portfolio, ranked #94.

683 Capital Management first reported a position in IFRX in Q2 2023 and has held it in 12 quarters since. The position peaked at $8.92M in Q2 2023. 35 funds tracked by Wall St. Rank hold IFRX as of Q1 2026.

  • 683 Capital Management held 3,315,000 shares of InflaRx worth $2.96M as of Q1 2026.
  • 683 Capital Management left its InflaRx share count unchanged in Q1 2026.
  • InflaRx made up 0.15% of 683 Capital Management's portfolio in Q1 2026, its #94 holding.
  • 683 Capital Management first reported a position in InflaRx in Q2 2023 and has held it in 12 quarters since.
  • 683 Capital Management's InflaRx position peaked at $8.92M in Q2 2023.
  • 35 funds tracked by Wall St. Rank held InflaRx as of Q1 2026.

Based on 683 Capital Management's 13F filing for Q1 2026, filed 15 May 2026.